Cargando…
COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab()
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292098/ https://www.ncbi.nlm.nih.gov/pubmed/36166252 http://dx.doi.org/10.1016/j.nefroe.2020.07.003 |
| _version_ | 1783724779172265984 |
|---|---|
| author | Baldallo, Cinthia León Román, Juan Carlos Seron, Daniel Agraz, Irene Solans, Roser Ramos, Natalia Soler, María José |
| author_facet | Baldallo, Cinthia León Román, Juan Carlos Seron, Daniel Agraz, Irene Solans, Roser Ramos, Natalia Soler, María José |
| author_sort | Baldallo, Cinthia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8292098 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82920982021-07-21 COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab() Baldallo, Cinthia León Román, Juan Carlos Seron, Daniel Agraz, Irene Solans, Roser Ramos, Natalia Soler, María José Nefrologia (Engl Ed) Letter to the Editor Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. 2021 2021-07-21 /pmc/articles/PMC8292098/ /pubmed/36166252 http://dx.doi.org/10.1016/j.nefroe.2020.07.003 Text en © 2020 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Baldallo, Cinthia León Román, Juan Carlos Seron, Daniel Agraz, Irene Solans, Roser Ramos, Natalia Soler, María José COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab() |
| title | COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab() |
| title_full | COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab() |
| title_fullStr | COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab() |
| title_full_unstemmed | COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab() |
| title_short | COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab() |
| title_sort | covid-19 in a patient with hypocomplementemic urticarial syndrome and mpo-anca vasculitis on hemodialysis treated with omalizumab() |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292098/ https://www.ncbi.nlm.nih.gov/pubmed/36166252 http://dx.doi.org/10.1016/j.nefroe.2020.07.003 |
| work_keys_str_mv | AT baldallocinthia covid19inapatientwithhypocomplementemicurticarialsyndromeandmpoancavasculitisonhemodialysistreatedwithomalizumab AT leonromanjuancarlos covid19inapatientwithhypocomplementemicurticarialsyndromeandmpoancavasculitisonhemodialysistreatedwithomalizumab AT serondaniel covid19inapatientwithhypocomplementemicurticarialsyndromeandmpoancavasculitisonhemodialysistreatedwithomalizumab AT agrazirene covid19inapatientwithhypocomplementemicurticarialsyndromeandmpoancavasculitisonhemodialysistreatedwithomalizumab AT solansroser covid19inapatientwithhypocomplementemicurticarialsyndromeandmpoancavasculitisonhemodialysistreatedwithomalizumab AT ramosnatalia covid19inapatientwithhypocomplementemicurticarialsyndromeandmpoancavasculitisonhemodialysistreatedwithomalizumab AT solermariajose covid19inapatientwithhypocomplementemicurticarialsyndromeandmpoancavasculitisonhemodialysistreatedwithomalizumab |